Addictions, Drug & Alcohol Institute

Publications


March 30, 2022

New ADAI Research: Cannabis Store Location and Advertising Influences Use by Oregon Youth

Cannabis store sidewalk sign with image of leaf and word OPEN

This new paper in Health and Place, led by Caislin Firth and in collaboration with the Oregon Health Authority, looks at the impact of retail cannabis store location and exposure to cannabis advertising on youth cannabis use. The project was partially funded by the National Institutes of Drug Abuse awarded to co-author Julia Dilley and the Horowitz Foundation…


March 8, 2022

Results from the 2021 WA State Syringe Service Program Health Survey

Title of report with map showing location of survey respondents

The biennial WA State Syringe Service Program Health Survey is the state’s primary source of data on the substance use patterns, health behaviors, and health care needs of people who use drugs and utilize syringe service programs (SSPs). The University of Washington’s Addictions, Drug & Alcohol Institute (ADAI) conducts the survey in collaboration with Public…


February 16, 2022

New from ADAI/FADU: Prenatal Alcohol Exposure and Mental Health at Midlife

Illustration of pregnant woman with text Prenatal Alcohol Exposure and Mental Health at Midlife

The effects of prenatal alcohol exposure (PAE) have been studied a lot, with a particular focus on physical birth defects and neurocognitive development. Much less studied has been an association between PAE and mental health disorders, especially for adults with both PAE and fetal alcohol spectrum disorders (FASD). Though some research has found a connection…


January 31, 2022

New from ADAI: Distributing Safer Smoking Supplies Can Help Reduce Health Risks of Opioid/Stimulant Use

Stack of 3 binders with New ADAI Report on the spines

In Washington State and across the country, fentanyl has quickly become a major opioid in the illicit drug supply. Fentanyl, especially in pill form, is most often smoked rather than injected. Similarly, methamphetamine is most typically smoked and its use and fatal overdoses have increased rapidly in recent years. Harm reduction programs, including syringe services programs (SSPs), do a great job…


January 26, 2022

New from ADAI: Cannabis Industry Marketing Violations in WA, 2014-2019

Cannabis store sidewalk sign with image of leaf and word OPEN

There’s a conflict between prevention and profit when it comes to marketing by the cannabis industry in Washington State, say ADAI researchers Beatriz Carlini, PhD, Sharon Garrett, MPH, MA, and Caislin Firth, PhD, MPH, and Rutgers researcher Ilana Pinsky, PhD. Engaging community members in monitoring for marketing rule violations could help keep that conflict in…


December 16, 2021

New ADAI Report: Housing Program Staff Want More Training to Address Substance Use

Stack of 3 binders with New ADAI Report on the spines

To learn more about the needs of housing professionals who work with people who use substances, ADAI staff Alison Newman, MPH and Susan Kingston conducted an anonymous, online survey in September 2021. The objectives of this survey were to: identify successes and challenges, determine how knowledgeable and comfortable staff feel in working with substance use,…


December 8, 2021

New ADAI Report: Dramatic Increases in Opioid Overdose Deaths Due to Fentanyl Among Young People in WA

Graph showing increases in overdose deaths

Use of illicitly manufactured fentanyl has had an outsized impact on overdose deaths in Washington State, according to a new report from ADAI/UW Psychiatry research scientists Caleb Banta-Green and Jason Williams. Fentanyl use and overdose deaths appear to mostly affect these populations: young adults inexperienced with opioid use young adults with rapid onset opioid use…


November 30, 2021

New Report: WA State Project to Prevent Prescription Drug/Opioid Overdose: Final Report on Naloxone Distribution

Stack of 3 binders with New ADAI Report on the spines

The Washington State Project to Prevent Prescription Drug/Opioid Overdose (WA-PDO) was a five-year project supported by the WA State Health Care Authority/Division of Behavioral Health and Recovery with funds from the Substance Abuse and Mental Health Services Administration. The goal of the project was to prevent opioid overdose in WA State by building a statewide…


October 21, 2021

New Report: Perspectives of People Who Use Methamphetamine on Reducing or Stopping Their Use

Stack of 3 binders with New ADAI Report on the spines

In spring 2021, Sierra Teadt, MPH(c) and Alison Newman, MPH interviewed 27 syringe services program participants who use methamphetamine. They learned more about why people use, their interest in reducing or stopping their methamphetamine use, and what services might help them improve their health and quality of life. The interviews revealed that most participants saw…


August 6, 2021

Cannabis Sales in WA, OR, AK, and CO Increase During COVID-19 Pandemic

Open glass jars of cannabis against blue background

Cannabis sales in Alaska, Colorado, Oregon, and Washington increased more during the COVID-19 pandemic than in the previous two years, according to this new study in the International Journal of Drug Policy from ADAI research scientist Gillian Schauer and colleagues – the first study to document changes in U.S. cannabis sales data during the pandemic….



Previous page Next page